ArticleLife (Basel, Switzerland)2022

Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients.

Alexander Fichte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.